CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Varenicline tartrate

Last Updated: March 21, 2007
Result type: Reports
Project Number: SR0094-000
Product Line: Reimbursement Review

Generic Name: Varenicline tartrate

Brand Name: Champix

Manufacturer: Pfizer Canada Inc.

Therapeutic Area: Smoking-cessation

Indications: Smoking-cessation

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: August 16, 2007

Recommendation Type: List with clinical criteria and/or conditions